AVALO THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
AVALO THERAPEUTICS, INC. (AVTX) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $10.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $10.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $17.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $28.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $40.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2026-06-30 | $10.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $28.00K 10-K · filed 2026-03-23 | |
| 2025-09-30 | $40.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $56.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $74.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $95.00K 10-K · filed 2025-03-20 | |
| 2024-09-30 | $303.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $340.00K 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $381.00K 10-Q/A · filed 2024-07-11 | |
| 2023-12-31 | $427.00K 10-K · filed 2024-03-29 | |
| 2023-09-30 | $465.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $512.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $562.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $614.00K 10-K · filed 2023-03-29 | |
| 2022-09-30 | $666.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $721.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $777.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $834.00K 10-K · filed 2022-03-02 | |
| 2021-09-30 | $428.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $451.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $474.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $496.74K 10-K · filed 2021-03-08 | |
| 2020-09-30 | $530.59K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $559.06K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $568.22K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $592.67K 10-K · filed 2020-03-11 | |
| 2019-09-30 | $624.70K 10-Q · filed 2019-11-14 | |
| 2019-03-31 | $648.19K 10-Q · filed 2019-08-08 | $671.18K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |